In this animal model of orthotopically implanted, docetaxel-resistant breast tumors, it was revealed that RPN2 silencing effectively facilitated the accumulation of docetaxel in tumor cells, augmented docetaxel-induced apoptotic cell death, and suppressed tumor growth. Here, RPN2 is linked to neoplasm.